| Name | Title | Contact Details |
|---|
Avaxia is a leader in the growing field of gut-targeted therapeutics — orally administered, minimally absorbed drugs that are designed to act locally in the gastrointestinal tract. Avaxia’s lead clinical candidate, AVX-470, is an oral anti-TNF antibody for inflammatory bowel disease. This transformative product offers potentially improved safety and efficacy over existing anti-TNF therapies by focusing immune suppression only where needed in the diseased gut. Avaxia plans to use its gut-targeted antibody platform to develop therapeutics to address many other serious diseases such as type 2 diabetes, celiac disease, GI acute radiation syndrome and oral mucositis.
Medical Business bureau is a Park Ridge, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Nicoya is a Canadian biotechnology company dedicated to improving human life by helping scientists succeed. Established in 2012, Nicoya develops innovative and accessible biosensor technology for in-depth characterization of biomolecular interactions. ...
Vertiflex is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in San Clemente, CA. To find more information about Vertiflex, please visit www.vertiflex.net
Southeast Colorado Hospital and LTCC is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Springfield, CO. To find more information about Southeast Colorado Hospital and LTCC, please visit www.sechosp.org